MyFastRx Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.8/10
Best for: month-to-month compounded semaglutide at $139, with cheaper prepaid plans
MyFastRx scores highest on the clinical side (which drugs it prescribes and how it doses) and lowest on availability. Its compounded semaglutide costs $139 a month, 30% below the $199 median among the sellers we compare.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
then $139/mo ongoing
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Prices checked October 2026
MyFastRx Health LLC sells compounded semaglutide at $139 a month and tirzepatide at $199, with the code MY70 taking $70 off the first month ($69 and $129). Prepaid plans cut the monthly rate, down to $79 and $124 a month on 12 months billed at once ($948 and $1,488). Provider review, medication and express shipping are included, and the price is generally flat across doses. It is cash-pay only, LegitScript-listed, and publishes no state list.
Is MyFastRx legit?
Yes. MyFastRx is a real, operating US company, and we found no FDA warning letters issued to it. Its site shows LegitScript certification. We rate it 7.8/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.
Is there a MyFastRx promo or coupon code?
MyFastRx publishes the code SAVE70 (Promo code SAVE70: $99 first month semaglutide (reg. $169/mo) / $179 first month tirzepatide (reg. $249/mo), saves $70, new customers only). You enter it at checkout on MyFastRx's own site. Other codes for MyFastRx circulate on coupon sites, and we cannot vouch for those.
See how MyFastRx compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Vetted alternatives to MyFastRx
Collective
Best for: flat any-dose pricing, if you can absorb a $199 annual membership on top
Editorial score · methodology
Embody
Best for: a flat compounded tirzepatide or semaglutide price at every dose, from a seller that names its pharmacies
Editorial score · methodology
Luvo Health
Best for: moving between compounded and brand without changing seller
Editorial score · methodology
MyFastRx at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $139/mo
- Pricing model
- Flat: the price stays the same as the dose goes up
- What's included
- Medication · Consult · Shipping
- FDA status
- No FDA warning letters found
How MyFastRx scores
Six columns, each one computed from something MyFastRx has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
7.6/10$139/month is 30% below the $199 median for compounded semaglutide across the sellers we compare.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
8.0/10A price is shown before the questionnaire starts.
Trust & Safety15%
6.5/10No pharmacy is named for its prescriptions. It shows a price before asking for health information.
Accessibility10%
5.0/10No state list is available to check, so this is held at the midpoint rather than scored on reach.
Support10%
7.0/10The price covers the medication, clinician visits and shipping.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on MyFastRx
Last checked October 2026- Checked the listed price across 2 dose or plan tiers
- Checked what the monthly price covers, and what it leaves out
- Checked FDA warning letters for MyFastRx
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with MyFastRx involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1MyFastRx shows a price on its own site before asking anything about you, so you can compare it with other sellers before you start a questionnaire.
- 2Ask MyFastRx which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- 3The monthly price includes the medication, clinician visits and shipping.
- Lowest ongoing monthly price: semaglutide $139, tirzepatide $199. That leaves out membership fees, first-month rates and insurance copays.
- Confirm that MyFastRx serves your state before you start.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
Cancelling MyFastRx
Taken from the terms MyFastRx publishes. Terms change, so check the current policy before you subscribe.
- Cancel any time
- Yes
- Minimum commitment
- Monthly refills carry no lock-in; longer bundles are charged in full when bought
- Refund policy
- Orders canceled before they reach the pharmacy can be refunded in full. Dispensed or shipped medication is final. Canceling a prepaid plan refunds the amount paid minus the received months repriced at the shorter plan rate.
- Early-termination fee
- None
Medications MyFastRx lists
MyFastRx lists compounded semaglutide and compounded tirzepatide. Each one has its own guide: how it works, the dosing schedule, the side effects that show up in practice, and what the trials measured.
Pricing
Prices re-verified
First month $69 with MY70, then $139/mo. Prepaid: 3 months $297 ($99/mo), 6 months $534 ($89/mo), 12 months $948 ($79/mo). Provider review, medication and express shipping included.
First month $129 with MY70, then $199/mo. Prepaid: 3 months $498, 6 months $894, 12 months $1,488 (about $124/mo).
Check the price yourself before you pay
Every figure here comes from MyFastRx's own website, as of the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Semaglutide costs $139 a month, 30% below the $199 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $199 a month, 26% below the $269 median for compounded tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price stays the same as your dose goes up
- The monthly price includes the medication, clinician visits and shipping
- We found no FDA warning letters issued to MyFastRx
Against it
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What MyFastRx charges
MyFastRx advertises $69. That buys the first month. The standing rate is $139/month, and that is the one worth doing the math on, because the introductory figure applies once.
- Compounded semaglutide: $69 first month, then $139/month
- Compounded tirzepatide: $129 first month, then $199/month
For compounded semaglutide, the median across the sellers we compare is $199/month, so MyFastRx's $139 is genuinely below the middle, not just advertised that way. Before you pay, compare MyFastRx's cancellation terms with other sellers' cancellation and refund policies. For scale, the dearest tenth of compounded sellers charges about three times the cheapest tenth.
Ivim Health, at about $140/month, is the closest like-for-like alternative we review.
What MyFastRx dispenses
MyFastRx prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the pair carrying the strongest published outcome data. The medication is compounded rather than dispensed as an approved pen. Compounding serves real clinical needs and is entirely lawful; what it is not is reviewed, and the cost difference reflects that. For what differs besides the price, see compounded semaglutide vs Ozempic and Wegovy.
Safety and disclosure
MyFastRx tells you its price before you start the medical questionnaire. We found no FDA warning letters issued to MyFastRx. Because the medication is compounded, the most useful question to ask at intake is which licensed pharmacy fills the prescription. If MyFastRx will not tell you, treat that as a warning sign. Once you have the pharmacy's name, 503A vs 503B explains which regulator oversees it and how to check. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Who should look elsewhere
- You would be choosing on the advertised figure. The introductory month is real, but it is not what you will pay in month three.
- You want the FDA-approved pen specifically. Everything listed here is compounded.
- You need insurance to cover the cost. Check whether MyFastRx bills your plan before you start.
It fits if
- the lowest standing monthly cost is what you are solving for
- you want the price to stop moving as your dose climbs
- you want a cheap way to find out whether the medication suits you before committing
Our read
MyFastRx is a cheap way to start and an ordinary way to continue. Use the $69 month for what it is good for, finding out whether the medication works for you, and re-run the numbers against $139/month before you let it renew twice.
The Bottom Line
MyFastRx scores highest on the clinical side (which drugs it prescribes and how it doses) and lowest on availability. Its compounded semaglutide costs $139 a month, 30% below the $199 median among the sellers we compare.
Before you pay MyFastRx
Starting at $139 a month. Check today's price, then start the intake.
Where MyFastRx is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these three counts, another seller does better.
- If you need the FDA-approved pen rather than a compounded vial, consider WellMedRx.
- If the standing monthly cost is what decides it, consider Collective (from $59/mo + membership).
- If you want a human checking in, not just a prescription, consider Eden.
If none of these fits, our guide to alternatives to MyFastRx sets more sellers in the same category beside MyFastRx on price, states and what the price includes.
Frequently Asked Questions
How to check MyFastRx yourself
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this MyFastRx review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of October 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Aronne LJ et al.)— New England Journal of Medicine.PMID: 40353578.
See MyFastRx's current pricing
Plans start at $69 a month. Whether you qualify is a clinician's decision, made after your intake.